A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients

NCT06199557 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia, Adult
Myelodysplastic Syndromes, Adult

Interventions

DRUG: Hydroxyurea, Hydroxycarbamide
DRUG: Valproic acid
DRUG: 6-Mercaptopurine (6-MP)

Sponsor

Haukeland University Hospital